[Synthetic progestins, such as medroxyprogesterone acetate (MPA), which are currently used in hormone replacement therapy may disrupt androgen receptor signaling and contribute to breast cancer developmoent/REVIEW]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine.
Gene-disease associations inferred from text-mining the literature.
DisGeNET evidence - LITERATURE